Legal Disclaimer

William Shaw Securities is a Corporate Authorised Representative of Novus Capital Limited AFSL 238168 ACN 006 711 995

Immunotherapies Pty Ltd trading as "William Shaw Securities" ("William Shaw") and Novus Capital Limited (Novus) , their associates and respective Directors and staff each declare that they, from time to time, may hold interests in securities and/or earn brokerage, fees, interest, or other benefits from products and services mentioned in this website.

This website might contain unsolicited general information, without regard to any investor's individual objectives, financial situation or needs. It is not specific advice for any particular investor. Before making any decision about the information provided, you must consider the appropriateness of the information in this website or the product disclosure statement or Financial Services Guide, having regard to your objectives, financial situation and needs and consult your adviser. Any indicative information and assumptions used here are summarised and also may change without notice to you, particularly if based on past performance.

William Shaw and Novus believes that any information or advice (including any securities recommendation) contained in this website is accurate when issued but does not warrant its accuracy or reliability. William Shaw and Novus is not obliged to update you if the information or its advice changes. William Shaw and Novus and each of their respective officers, agents and employees exclude to the full extent permitted by law, all liability of any kind, in negligence, contract, under fiduciary duties or otherwise, for any loss or damage, whether direct, indirect, consequential or otherwise, whether foreseeable or not, to the extent arising from or in connection with this website.